The newly funded projects focus on the development of informatics infrastructure for sharing genomic and clinical data to better manage patient care.
The grant, made through Innovate UK, will specifically fund a collaboration between Oxford Genetics and researchers at the University of Oxford.
A team of Swedish researchers has received $3.3 million to develop a new nanotechnology platform for detecting blood-borne markers in lung and breast cancer.
The team will use the new research grant to further develop the Stockholm3 prostate cancer test and to design follow-on diagnostics to help treat patients with the disease.
The funds will support TGen's efforts to use graphics processing units to reduce single-cell transcriptome data analysis times from months to days.
St. Louis-based Benson Hill will receive a grant from the NCGA, and will work with the group on breeding corn using its CropOS informatics platform.
The projects focus on early treatment of prostate cancer and cataloguing mutations in difficult-to-diagnose diseases, among other things.
The project is the consumer genomics firm's latest effort to improve diversity in genetics research.
The consortium aims to profile up to 800 multiple myeloma patient samples using the Affymetrix platform with a goal of developing a list of predictive biomarkers.
The agency says the Safe Genes program will help provide the genome editing field with tools to safely pursue research and to get out in front of new threats.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.